Bluebird Bio Total Assets 2012-2021 | BLUE

Bluebird Bio total assets from 2012 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Bluebird Bio Annual Total Assets
(Millions of US $)
2020 $1,781
2019 $1,727
2018 $2,243
2017 $1,901
2016 $1,118
2015 $1,002
2014 $557
2013 $224
2012 $69
2011 $31
Bluebird Bio Quarterly Total Assets
(Millions of US $)
2021-09-30 $1,340
2021-06-30 $1,454
2021-03-31 $1,637
2020-12-31 $1,781
2020-09-30 $1,945
2020-06-30 $2,108
2020-03-31 $1,529
2019-12-31 $1,727
2019-09-30 $1,892
2019-06-30 $2,023
2019-03-31 $2,139
2018-12-31 $2,243
2018-09-30 $2,352
2018-06-30 $1,762
2018-03-31 $1,867
2017-12-31 $1,901
2017-09-30 $1,406
2017-06-30 $1,457
2017-03-31 $1,073
2016-12-31 $1,118
2016-09-30 $918
2016-06-30 $942
2016-03-31 $979
2015-12-31 $1,002
2015-09-30 $1,018
2015-06-30 $999
2015-03-31 $534
2014-12-31 $557
2014-09-30 $330
2014-06-30 $241
2014-03-31 $210
2013-12-31 $224
2013-09-30 $228
2013-06-30 $235
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2011-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.698B $0.251B
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.357B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90